GlassScriptPhysician profile
Abdulkadir Omer
NPI 1750548996
$2,034.80
in general payments reported to CMS, 2019-2025
19 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.03 · 2021: $292 · 2022: $391 · 2023: $526 · 2024: $500 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $457.28 | 2020-2025 | Ozempic |
| Lilly USA, LLC | $328.03 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $124.83 | 2024-2025 | Freestyle Libre 3, Amplatzer Talisman |
| Astrazeneca Pharmaceuticals LP | $123.10 | 2021-2023 | Farxiga |
| Amgen INC. | $119.73 | 2022-2025 | Evenity |
| Cequr Corporation | $113.27 | 2022 | |
| Corcept Therapeutics | $104.97 | 2022-2023 | Korlym |
| Medtronic, INC. | $101.57 | 2023-2024 | Minimed 780g, Intellis Adaptivestim, Minimed 630g |
| Tandem Diabetes Care, INC. | $93.20 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $88.11 | 2023-2025 | Yorvipath |
| Novartis Pharmaceuticals Corporation | $83.16 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $66.12 | 2022-2023 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.72 | 2020-2024 | Jardiance |
| Recordati_rare_diseases_inc. | $49.87 | 2023 | Isturisa, Signifor Lar |
| Sanofi-Aventis U.S. LLC | $33.60 | 2022-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $27.76 | 2023 | Tymlos |
| Kyowa Kirin, INC. | $23.08 | 2025 | |
| Mannkind Corporation | $21.09 | 2022 | |
| Dexcom, INC. | $19.31 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdulkadir Omer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.